共 142 条
- [1] Otsuka T(2021)A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study Int J Clin Oncol 26 941-950
- [2] Shirakawa T(2021)Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma Ann Gastroenterol Surg 5 7-23
- [3] Shimokawa M(2020)History of pancreatic surgery in Japan: Respect to the Japanese pioneers of pancreatic surgery Ann Gastroenterol Surg 4 118-125
- [4] Ishido K(2020)From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer Nat Rev Clin Oncol 17 108-123
- [5] Hakamada K(2021)Prognostic value of the memorial sloan kettering prognostic score in metastatic pancreatic adenocarcinoma Cancer 127 1568-1575
- [6] Kimura N(2019)Optimizing the outcomes of pancreatic cancer surgery Nat Rev Clin Oncol 16 11-26
- [7] Yamaue H(2021)Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients Int J Clin Oncol 26 543-551
- [8] Nevala-Plagemann C(2021)Aging, cancer, and antitumor immunity Int J Clin Oncol 26 883-892
- [9] Hidalgo M(2021)Survival benefit of adjuvant chemotherapy in elderly patients with colon cancer: a systematic review and meta-analysis Int J Clin Oncol 26 199-206
- [10] Garrido-Laguna I(2021)Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study) Int J Clin Oncol 381 752-762